Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine: Intravenous dexmedetomidine 0.5microgram/kg in 100ml normal saline as bolus dose, ten minutes prior to subarachnoid block with Bupivacaine.
Control Intervention1: Norma
Sponsors
VARSHINI R V
Eligibility
Inclusion criteria
Inclusion criteria: Patients admitted for Elective lower abdominal surgeries under spinal anaesthesia with ASA grades 1 and 2
Exclusion criteria
Exclusion criteria: Patient refusal Contraindications to regional anaesthesia Patients with hepatic and renal impairment Patients taking Beta blockers and steroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of sensory block motor block and analgesia in spinal anaesthesiaTimepoint: Intraoperative period and postoperative period until full recovery of sensory and motor function up to 4 hours post spinal anaesthesia | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic parameters Level of sedation and Adverse effects in spinal anaesthesiaTimepoint: Intraoperative period and postoperative period until full recovery of sensory and motor function up to 4 hours post spinal anaesthesia | — |
Countries
India
Contacts
Public ContactVARSHINI R V
PSG Institute of Medical Sciences and Research
Outcome results
None listed